Nj State Employees Deferred Compensation Plan Organon & Co. Transaction History

Nj State Employees Deferred Compensation Plan

$824 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Jan 26, 2023	BUY	$23.31 - $28.61 $187,062 - $229,595	8,025 New	8,025 $0
Q2 2021 Jul 23, 2021	BUY	$28.45 - $38.0 $228,311 - $304,950	8,025 New	8,025 $243,000

Others Institutions Holding OGN

# of Institutions

791

Shares Held

193M

Call Options Held

1.71M

Put Options Held

865K

Black Rock Inc. New York, NY

32.6M
Shares

$498 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

30.2M
Shares

$461 Million
0.01% of portfolio
Massachusetts Financial Services CO Boston, MA

9.76M
Shares

$149 Million
0.06% of portfolio
State Street Corp Boston, MA

8.98M
Shares

$137 Million
0.01% of portfolio
Lsv Asset Management Chicago, IL

7.49M
Shares

$115 Million
0.31% of portfolio

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nj State Employees Deferred Compensation Plan, based on Form 13F filings with the SEC.

News

Stay updated on Nj State Employees Deferred Compensation Plan with notifications on news.

Account